Prevalence of tetanus immunity in the Egyptian population
- PMID: 12237476
Prevalence of tetanus immunity in the Egyptian population
Abstract
Our aim was to determine the level of tetanus immunity in the general Egyptian population. The surveyed population consisted of 709 healthy subjects from five regions of Egypt, 2 month to 105 years of age. We used an ELISA assay to determine titers of anti-tetanus IgG. According to the widely used criteria, 31.7% was susceptible to tetanus (IgG level < 0.15 IU/ml), 15.7% protection (0.15-1.0 IU/ml), and 52.6% > or = 1.0 IU/ml). The results revealed that the majority (68.3%) population from 2 months to 50 years had a protective level of IgG against tetanus. The level of susceptibility increases with age until it reaches 90.3% Significantly, more males (23.7%) unprotected against tetanus. Our results suggest that monitoring immunization status and administering the tetanus vaccine as required are essential to insure adequate and long-lasting antibody levels.
Similar articles
-
Community-based seroepidemiology of tetanus in three selected provinces in Turkey.Jpn J Infect Dis. 2004 Feb;57(1):10-6. Jpn J Infect Dis. 2004. PMID: 14985630
-
Protection against tetanus in the aged people in the Czech Republic--cross-sectional study.Arch Gerontol Geriatr. 2005 Mar-Apr;40(2):123-8. doi: 10.1016/j.archger.2004.07.002. Arch Gerontol Geriatr. 2005. PMID: 15680496
-
Tetanus antibody assay combining in-house ELISA and particle agglutination test and its serosurvey application in a province in Turkey.Jpn J Infect Dis. 2004 Jun;57(3):97-102. Jpn J Infect Dis. 2004. PMID: 15218217
-
Tetanus IgG antibody levels in children aged 12 to 47 months in Turkey.Am J Infect Control. 2001 Apr;29(2):120-3. doi: 10.1067/mic.2001.112687. Am J Infect Control. 2001. PMID: 11287881
-
[Assessment of the tetanus immune status in plasma donors of the Blood Donor Service of the Bavarian Red Cross].Dtsch Med Wochenschr. 2005 Aug 5;130(31-32):1810-3. doi: 10.1055/s-2005-871900. Dtsch Med Wochenschr. 2005. PMID: 16052443 German.
Cited by
-
Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial.Drugs Aging. 2013 May;30(5):309-19. doi: 10.1007/s40266-013-0065-0. Drugs Aging. 2013. PMID: 23494214 Free PMC article. Clinical Trial.
-
Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.PLoS One. 2016 Mar 2;11(3):e0149970. doi: 10.1371/journal.pone.0149970. eCollection 2016. PLoS One. 2016. PMID: 26934372 Free PMC article. Clinical Trial.
-
Serological Monitoring Is Key To Sustain Progress of the Maternal and Neonatal Tetanus Elimination Initiative.Clin Vaccine Immunol. 2016 Jul 5;23(7):532-4. doi: 10.1128/CVI.00259-16. Print 2016 Jul. Clin Vaccine Immunol. 2016. PMID: 27226278 Free PMC article.
-
Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma.Virol J. 2012 Sep 16;9:201. doi: 10.1186/1743-422X-9-201. Virol J. 2012. PMID: 22978304 Free PMC article.
-
Prevalence and socio-demographic factors associated with non-protective immunity against tetanus among high school adolescents girls in Nigeria.Ital J Pediatr. 2014 Mar 17;40(1):29. doi: 10.1186/1824-7288-40-29. Ital J Pediatr. 2014. PMID: 24636576 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical